Hasan ORHAN, Ganime SADIKOĞLU, Alis ÖZÇAKIR, Nazan Gonul BİLGEL

Metabolic Syndrome among Women: A Study from Bursa Turkey

AMAÇ: Obezite metabolik sendromdaki risk faktörlerinden biridir ve Türkiye'deki prevalansı giderek artmaktadır. Bu çalışmanın amacı 20 yaş ve üzeri kadınlarda metabolik sendrom ve obezite sıklığını araştırmaktır. YÖNTEM: Kesitsel bir çalışmadır. Bursa'da birinci basamak sağlık hizmeti veren bir kuruluşta 2008 yılında yapılmıştır. Toplam 807 kadın çalışmaya alınmıştır. Katılımcıların ağırlık, boy, bel çevresi, kan basıncı, toplam ve HDL kolesterol, açlık kan şekeri ve trigliserid düzeyleri ölçülmüştür. Metabolik sendrom tanısı Uluslararası Diabet Federasyonu kriterlerine göre konulmuştur. BULGULAR: Katılımcıların yaş ortalaması 42,7±13,2'dir. Yüzde 96,4'ü evlidir. Yüzde 50,7'sinin eğitim düzeyi 8 yılın altındadır. Yüzde 93,7'si ev kadınıdır ve %85,3'ünün aylık aile geliri 650$ veya altındadır. Metabolik sendrom ve abdominal obezite prevalansı sırasıyla %17,5 ve %87,7 olarak bulunmuştur. Diyabeti ve yüksek kan yağlarına sahip olanlarda metabolik sendrom oluşma riski sırasıyla 11,3 ve 4,5 kez daha fazladır. Metabolik sendrom görülme riski yaşla ve vücut kitle indeksinin artmasıyla artmaktadır. SONUÇ: Çalışmamıza katılan kadınlarda obezite ve abdominal obezitenin yaygın olduğu saptanmıştır. Bel çevresi uzunluğundaki ve vücut kitle indeksindeki artışa rağmen metabolik sendrom prevalansının düşük bir düzeyde oluşu açıklanamamıştır. Trigliserid düzeyindeki düşüklük ve yüksek dansiteli lipoprotein kolesterol düzeyindeki yükseklik konularının daha ileri biçimde araştırılması gerekir. Kesitsel ve tek bir merkezde yapılan bir çalışma olması nedeniyle bu çalışmanın sonuçları genelleştirilmemelidir

Kadınlarda Metabolik Sendrom: Bursa Türkiye’de Yapılan Bir Çalışma

AIM: Obesity is one of the risk factors of metabolic syndrome (MetS) and its prevalence is rapidly increasing in Turkey. The purpose of this study was to assess the prevalence of MetS and obesity among women aged 20 years and older. METHOD: This is a cross- sectional study, undergone in a primary health care setting in Bursa /Turkey in the year 2008. A total of 807 women were included in the study. Body weight, height, waist circumference, blood pressure, total and HDL cholesterol, fasting plasma glucose and triglyceride levels were measured. Metabolic Syndrome definition was made according to the International Diabetes Federation (IDF) criteria. RESULTS: The mean age was 42.7±13.2 years, 96.4% were married, 50.7% had education of less than 8 years, 93.7% were housewives and 85.3% had a monthly family income of $650 or less. The prevalence of MetS and abdominal obesity were 17.5% and 87.7% respectively. Those with diabetes mellitus and elevated plasma lipids had increased risk of developing MetS 11.3 and 4.5 times more than those without these situations respectively. The risk of MetS increases with age and increasing BMI. CONCLUSION: In conclusion it can be stated that obesity and central obesity are alarmingly frequent among the adult Turkish women who participated in our study. Despite the high prevalence of elevated waist circumference and body mass index the low prevalence of MetS could not be explained. The low levels of triglycerides and high levels of high density lipoprotein cholesterol should be studied further. Because of its cross-sectional and single center oriented design the results of this study should not be generalized

PDF

___

1 Timar O, Sestier F, Levy E. Metabolic Syndrome X: a review. Can J Cardiol. 2000; 16: 779-789.
2 Lindberg O, Tilvis RS, Strandberg TE, et al. Impacts of components of the metabolic syndrome on health status and survival in an aged population. Eur J Epidemiol. 1997; 13: 429-434.
3 WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva, WHO, 1999.
4 Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group fort he study of Insulin Resistance (EGIR). Diabet Med. 1999; 16: 442- 443.
5 NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA. 2001; 285: 2486-2497.
6 Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9: 237-252.
7 Alberti KM, Zimmet P, Shaw J. The metabolic syndrome- a new worldwide definition. Lancet. 2005; 366: 1059-1062.
8 Assmann G, Guerra R, Fox G, et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007; 99: 541-548.
9 Ford ES. Prevalence of the metabolic syndrome defined by the Interanational Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28: 2745-2749.
10 Choi KM, Kim SM, Kim YE, Choi DS, Baik SH. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Educating Program and International Diabetes Federation definitions in the Korean population. Metabolism. 2007; 56: 552-558.
11 Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract. 2007; 77: 471-478.
12 Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest. 2007; 37: 109-116.
13 Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Educating Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005; 28: 2588a- 2589.
14 Sanisoglu Y, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence of metabolic syndrome related disorders in a large adult population in Turkey. BMC Public Health. 2006; 6: 92 http://www.biomedcentral.com/1471-2458/6/92 [Accessed date: 25.08.2010]
15 Can AS, Bersot T P. Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health. 2007; 7: 353 http://www.biomedcentral.com/1471-2458/7/353 [Accessed date: 25.08.2010]
16 Kozan O, Oguz A, Abaci A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr. 2007; 6: 548-553.
17 Ozsahin AK, Gokcel A, Sezgin N, et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab. 2004; 17: 230-234.
18 Kitis Y, Bilgili N, Hisar F, Ayaz S. Frequency and affecting factors of metabolic syndrome in women older than 20 years of age. Anadolu Kardiyol Derg. 2010; 10: 111-119. [Accessed date: 27.10.2010]
19 Mahley RW, Palaoglu KE, Atak Z, et al. Turkish heart study. Lipids, lipoproteins, and alipoproteins. J Lipid Res. 1995; 36: 839-859.
20 Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels a prospective and crosssectional evaluation. Atherosclerosis. 2002; 165: 285-292.
21 WHO: Obesity in Europe. World Health Organization, Copenhagen, 2006. www.euro.who.int/obesity [Accessed date: 22.11.2010]
22 WHO. The European Health Report, 2005. Public health action for healthier children and populations. World Health Organization, Copenhagen,_2005._http://www.euro.who.int/do cument/e87325.pdf [Accessed date: 22.11.2010]
23 Turkey Demographic and Health Survey 2008. Hacettepe University Institute of Population Studies, Ministry of Health General Directorate of Mother and Child Health and Family Planning, T.R. Prime Ministry Undersecretary of State Planning Organization and TUBITAK, Ankara,_2009._http://www.hips.hacettepe.edu.tr /eng/tdhs08/TDHS-2008_Main_Report.pdf [Accessed date: 21.08.2009]
24 WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series, 894. World Health Organization, Geneva, 2002
25 Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am. 2004; 112: 2735-2752.
26 Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among adults; findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002; 289: 76-79.
27 Taylor H, Liu J, Wilson G, et al. Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study. Diabetes Care. 2008; 31: 1248-1253.
28 Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007; 7: 220 http://www.biomedcentral.com/1471-2458/7/220 [Accessed date: 28 .08.2010].
29 Mangat C, Goel NK, Walia DK, et al. Metabolic Syndrome: a challenging health issue in highly urbanized union territory of North India. Diabetol Metab Syndr. 2010; 2:19. [Accessed date: 17.11.2010]
30 Rojas R, Aguilar-Salinas C, Jimenez-Corona A, et al. Metabolic syndrome in Mexican adults. Results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010; 52(1): S11-S18 [Accessed date: 23.08.2010]
31 Sidorenkov O, Nilssen O, Bren T, Martiushov S, Arkhipvsky VL, Grjbovski AM. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health 2010; 10: 23. http://www.biomedcentral.com/1471-2458/10/23 [Accessed date: 5.10.2010]
32 Dallongeville J, Cottel D, Ferrieres J, et al. Household income is associated with the risk of metabolic syndrome in a sex specific manner. Diabetes Care. 2005; 28: 409-415 [Accessed date: 15.08.2010]
33 Tanyolac S, Cikim AS, Azezli AD, Orhan Y. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population. Anadolu Kardiyol Derg 2008; 8:336-341. http://www.anakarder.com/sayilar/39/371.377.p df [Accessed date: 15.08.2010]
34 Onat A, Hergenc G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type II diabetes in Turkey. Anadolu Kardiyol Derg. 2006; 6: 314-321. http://www.anakarder.com/sayilar/36/210.211.p df [Accessed date: 15.08.2010]
35 Altun B, Arici M, Nergizoglu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005; 23: 1817-1823.
36 Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009; 31: 47-58.